Descripción del proyecto
Nueva terapia personalizada para la prevención y el tratamiento de la artrosis
La restauración de la homeostasis fisiológica articular en la artrosis incipiente puede prevenir la progresión de la enfermedad. El equipo del proyecto PROTO, financiado con fondos europeos, se propone desarrollar nuevas estrategias de tratamiento basadas en pruebas y centradas en el paciente para las etapas previas o tempranas de la artrosis. Los pacientes con artrosis incipiente de rodilla serán tratados con inyecciones locales de células expandidas de placenta, un nuevo producto de terapia celular alogénica con características antiinflamatorias que pueden prevenir o impedir la progresión de la enfermedad. En un segundo enfoque, los pacientes que se recuperan de reconstrucciones del ligamento cruzado anterior, con patrones de marcha anormales que conducen a artrosis de rodilla, serán tratados con una intervención de entrenamiento digital personalizada basada en sensores. El objetivo es prevenir la progresión de la enfermedad al restablecer el movimiento normal y reducir la inflamación articular.
Objetivo
Osteoarthritis (OA) is the most common form of arthritis worldwide. Chronic low-grade inflammation in the articular environment causes cartilage degeneration at an early disease stage, resulting in chronic pain, disability and loss of independence due to progressive joint destruction. To date, no treatment is available to sustainably combat low-grade inflammation in early-stage OA patients. Biomechanical causes for intra-articular inflammation and OA development have been detected in specific patient groups.
The PROTO consortium strives to implement new evidence- and patient-centred treatment strategies for early- and pre-disease stages. For the first time, early-stage knee OA patients will be treated with local PLX-PAD injections, a novel allogeneic cell therapy product with distinct anti-inflammatory capacities that may halt or revert disease progression. Secondly, patients recovering from anterior cruciate ligament reconstructions with pathological gait patterns leading to knee OA, will be treated with a personalized sensor-based digital training intervention. We intend to prevent health to disease transition by restoring physiological movement and reducing joint inflammation.
To assess treatment success in early- and pre-stage OA, PROTO gathers scientific and clinical specialists who have genuinely shaped clinical, radiological and biomarker outcome parameters for OA in recent years. This will be the first time that these renowned experts join forces to analyze, stratify and compare fundamentally novel disease modifying treatment strategies for OA in one consortium. PROTO was developed with the help of patient organizations, industry partners and research societies.
Restoring physiological joint homeostasis at an early disease stage may be the key to understanding health to disease progression in OA. Targeting this ‘window of opportunity’ will fundamentally change the way OA is treated today and in the future.
Ámbito científico
Palabras clave
Programa(s)
Convocatoria de propuestas
Consulte otros proyectos de esta convocatoriaRégimen de financiación
HORIZON-RIA - HORIZON Research and Innovation ActionsCoordinador
10117 Berlin
Alemania